I also chair our geriatric and long-term care committee that reviews specific deaths in long-term care facilities. This is certainly a hot topic within the industry.
The answer is, in selected circumstances, under conditions such that there is a trial of a dose and a withdrawal if there's no improvement, it might be appropriate. But there's no question that the widespread use of anti-psychotics in long-term care facilities is a factor in the deaths of individuals in those facilities.